Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease

BMC Pulmonary Medicine

Volumn 10, Issue , 2010, Pages

  Moré, Jayaji M ^a,b   Voelker, Dennis R ^a   Silveira, Lori J ^a   Edwards, Michael G ^c   Chan, Edward D ^a   Bowler, Russell P ^a  

^a DEPARTMENT OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID; SURFACTANT PROTEIN D; BIOLOGICAL MARKER;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG LAVAGE; MALE; PREDICTOR VARIABLE; SMOKING; SPIROMETRY; AGED; CHEMISTRY; LUNG; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; SMOKE;

ADULT; AGED; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; REGRESSION ANALYSIS; SMOKE; SMOKING; SPIROMETRY; YOUNG ADULT;

EID: 77958141506     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-10-53     Document Type: Article

References (32)

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. Respiratory care 2002, 47(10):1184-1199.
2. Sin DD, Pahlavan PS, Man SF. Surfactant protein D: a lung specific biomarker in COPD?. Ther Adv Respir Dis 2008, 2(2):65-74. 10.1177/1753465808088903, 19124360.
3. Sorensen GL, Hjelmborg JB, Kyvik KO, Fenger M, Hoj A, Bendixen C, Sorensen TI, Holmskov U. Genetic and environmental influences of surfactant protein D serum levels. Am J Physiol Lung Cell Mol Physiol 2006, 290(5):L1010-1017. 10.1152/ajplung.00487.2005, 16361352.
4. Guo X, Lin HM, Lin Z, Montano M, Sansores R, Wang G, DiAngelo S, Pardo A, Selman M, Floros J. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur Respir J 2001, 18(3):482-490. 10.1183/09031936.01.00043401, 11589345.
5. Guo X, Lin HM, Lin Z, Montano M, Sansores R, Wang G, DiAngelo S, Pardo A, Selman M, Floros J. Polymorphisms of surfactant protein gene A, B, D, and of SP-B-linked microsatellite markers in COPD of a Mexican population. Chest 2000, 117(5 Suppl 1):249S-250S.
6. Hersh CP, Demeo DL, Lange C, Litonjua AA, Reilly JJ, Kwiatkowski D, Laird N, Sylvia JS, Sparrow D, Speizer FE, et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005, 33(1):71-78. 10.1165/rcmb.2005-0073OC, 2715305, 15817713.
7. Mutti A, Corradi M, Goldoni M, Vettori MV, Bernard A, Apostoli P. Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. Chest 2006, 129(5):1288-1297. 10.1378/chest.129.5.1288, 1472634, 16685021.
8. Lomas DA, Silverman EK, Edwards LD, Locantore NW, Miller BE, Horstman DH, Tal-Singer R. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J 2009, 34(1):95-102. 10.1183/09031936.00156508, 19164344.
9. Kobayashi H, Kanoh S, Motoyoshi K. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking. Biomarkers 2008, 13(4):385-392. 10.1080/13547500801903651, 18595202.
10. Sin DD, Man SF, Marciniuk DD, Ford G, FitzGerald M, Wong E, York E, Mainra RR, Ramesh W, Melenka LS, et al. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 177(11):1207-1214. 10.1164/rccm.200709-1356OC, 18310480.
11. Hirama N, Shibata Y, Otake K, Machiya J, Wada T, Inoue S, Abe S, Takabatake N, Sata M, Kubota I. Increased surfactant protein-D and foamy macrophages in smoking-induced mouse emphysema. Respirology 2007, 12(2):191-201. 10.1111/j.1440-1843.2006.01009.x, 17298450.
12. Betsuyaku T, Kuroki Y, Nagai K, Nasuhara Y, Nishimura M. Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid. Eur Respir J 2004, 24(6):964-970. 10.1183/09031936.04.00064004, 15572540.
13. Honda Y, Takahashi H, Kuroki Y, Akino T, Abe S. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 1996, 109(4):1006-1009. 10.1378/chest.109.4.1006, 8635323.
14. Fabbri LM, Hurd SS. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J 2003, 22(1):1-2. 10.1183/09031936.03.00063703, 12882441.
15. Chiba H, Pattanajitvilai S, Evans AJ, Harbeck RJ, Voelker DR. Human surfactant protein D (SP-D) binds Mycoplasma pneumoniae by high affinity interactions with lipids. J Biol Chem 2002, 277(23):20379-20385. 10.1074/jbc.M201089200, 11916969.
16. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37(8):911-917.
17. Rouser G, Siakotos AN, Fleischer S. Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids 1966, 1(1):85-86. 10.1007/BF02668129, 17805690.
18. Finley TN, Ladman AJ. Low yield of pulmonary surfactant in cigarette smokers. N Engl J Med 1972, 286(5):223-227. 10.1056/NEJM197202032860501, 5066599.
19. Nomori H, Horio H, Fuyuno G, Kobayashi R, Morinaga S, Suemasu K. Serum surfactant protein A levels in healthy individuals are increased in smokers. Lung 1998, 176(6):355-361. 10.1007/PL00007617, 9780293.
20. Gruber MP, Coldren CD, Woolum MD, Cosgrove GP, Zeng C, Baron AE, Moore MD, Cool CD, Worthen GS, Brown KK, et al. Human lung project: evaluating variance of gene expression in the human lung. Am J Respir Cell Mol Biol 2006, 35(1):65-71. 10.1165/rcmb.2004-0261OC, 2658699, 16498083.
21. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005, 5(1):58-68. 10.1038/nri1528, 15630429.
22. McCormack FX, Gibbons R, Ward SR, Kuzmenko A, Wu H, Deepe GS. Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 2003, 278(38):36250-36256. 10.1074/jbc.M303086200, 12857753.
23. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, Kim KS, McCormack FX. Surfactant proteins A and D inhibit the growth of Gram- negative bacteria by increasing membrane permeability. J Clin Invest 2003, 111(10):1589-1602. 155045, 12750409.
24. LeVine AM, Whitsett JA, Hartshorn KL, Crouch EC, Korfhagen TR. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 2001, 167(10):5868-5873.
25. LeVine AM, Whitsett JA, Gwozdz JA, Richardson TR, Fisher JH, Burhans MS, Korfhagen TR. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 2000, 165(7):3934-3940.
26. Ohya M, Nishitani C, Sano H, Yamada C, Mitsuzawa H, Shimizu T, Saito T, Smith K, Crouch E, Kuroki Y. Human pulmonary surfactant protein D binds the extracellular domains of Toll-like receptors 2 and 4 through the carbohydrate recognition domain by a mechanism different from its binding to phosphatidylinositol and lipopolysaccharide. Biochemistry 2006, 45(28):8657-8664. 10.1021/bi060176z, 16834340.
27. Yamazoe M, Nishitani C, Takahashi M, Katoh T, Ariki S, Shimizu T, Mitsuzawa H, Sawada K, Voelker DR, Takahashi H, et al. Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced inflammatory cell responses by altering LPS binding to its receptors. J Biol Chem 2008, 283(51):35878-35888. 10.1074/jbc.M807268200, 18990700.
28. Mehta H, Nazzal K, Sadikot RT. Cigarette smoking and innate immunity. Inflamm Res 2008, 57(11):497-503. 10.1007/s00011-008-8078-6, 19109742.
29. Numata M, Chu H, Dakhama A, Voelker DR. Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus induced inflammation and infection. Proc Natl Acad Sci USA 2009, 2806703, 20080799.
30. Kuronuma K, Mitsuzawa H, Takeda K, Nishitani C, Chan ED, Kuroki Y, Nakamura M, Voelker DR. Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2. J Biol Chem 2009, 284(38):25488-25500. 10.1074/jbc.M109.040832, 2757950, 19584052.
31. Schmekel B, Khan AR, Linden M, Wollmer P. Recoveries of phosphatidylcholine and alveolar macrophages in lung lavage from healthy light smokers. Clin Physiol 1991, 11(5):431-438. 10.1111/j.1475-097X.1991.tb00815.x, 1934939.
32. Ratjen F, Rehn B, Costabel U, Bruch J. Age-dependency of surfactant phospholipids and surfactant protein A in bronchoalveolar lavage fluid of children without bronchopulmonary disease. Eur Respir J 1996, 9(2):328-333. 10.1183/09031936.96.09020328, 8777972.